75626-001-02 : NDC 2026 Code

75626-001-02 : Voclosporin ( Lupkynis )

Additionally :

You can get information about “75626-001-02” NDC code in 75626-001-02 in HTML format

HTML | 75626-001-02 in TXT (Plain Text) format

TXT | 75626-001-02 in PDF (Portable Document Format)

PDF | 75626-001-02 in XML format

XML formats.

NDC Code : 75626-001-02 – JSON Data Format

                
{
  "NDC": {
    "NDCCode": "75626-001-02",
    "PackageDescription": "3 PACKET in 1 CARTON (75626-001-02)  / 4 BLISTER PACK in 1 PACKET (75626-001-01)  / 15 CAPSULE in 1 BLISTER PACK",
    "NDC11Code": "75626-0001-02",
    "ProductNDC": "75626-001",
    "ProductTypeName": "HUMAN PRESCRIPTION DRUG",
    "ProprietaryName": "Lupkynis",
    "ProprietaryNameSuffix": null,
    "NonProprietaryName": "Voclosporin",
    "DosageFormName": "CAPSULE",
    "RouteName": "ORAL",
    "StartMarketingDate": "20210122",
    "EndMarketingDate": null,
    "MarketingCategoryName": "NDA",
    "ApplicationNumber": "NDA213716",
    "LabelerName": "Aurinia Pharma U.S., Inc.",
    "SubstanceName": "VOCLOSPORIN",
    "StrengthNumber": "7.9",
    "StrengthUnit": "mg/1",
    "Pharm_Classes": "Calcineurin Inhibitor Immunosuppressant [EPC], Calcineurin Inhibitors [MoA], Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA], Organic Anion Transporting Polypeptide 1B3 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]",
    "DEASchedule": null,
    "Status": "Active",
    "LastUpdate": "2025-10-23",
    "PackageNdcExcludeFlag": "N",
    "ProductNdcExcludeFlag": "N",
    "ListingRecordCertifiedThrough": "20261231",
    "StartMarketingDatePackage": "20210122",
    "EndMarketingDatePackage": null,
    "SamplePackage": "N"
  }
}